The 20 Best Merkel Cell Carcinoma Doctors Near Me in Maryland, US

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine.

Isaac Brownell is a Dermatologist practicing medicine in Bethesda, Maryland. Dr. Brownell is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Muir-Torre Syndrome, Warts, and Sebaceous Adenoma.

Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology. Dr. Topalian is rated as a Distinguished provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as a Distinguished provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy. Dr. Taube is board certified in American Board Of Pathology.

"Daniel J. Lewis, M.D. is a dual fellowship-trained Mohs and reconstructive surgeon and Assistant Professor of Dermatology at Johns Hopkins University School of Medicine. He leads the Mohs surgery unit at the Johns Hopkins Outpatient Center (JHOC), the hospital's flagship facility in downtown Baltimore. He is also heavily involved in education as the director of the JHOC resident surgery clinic and as core faculty for the Micrographic Surgery and Dermatologic Oncology fellowship. Dr. Lewis earned a B.A. in Biology from the University of Pennsylvania, earned his M.D. at Baylor College of Medicine while completing a research fellowship at The University of Texas MD Anderson Cancer Center, and completed his internship at Memorial Sloan Kettering Cancer Center. He then returned to Penn for dermatology residency, serving as chief resident at the country's No. 1-ranked dermatology program by Doximity. At Penn, he pursued further specialization with two year-long post-doctoral fellowships in cutaneous oncology and Mohs micrographic surgery. During his Mohs fellowship at Penn, Dr. Lewis worked at the largest academic Mohs surgery center in the country alongside leaders in the field and pioneers in the use of Mohs surgery with immunohistochemistry, complex reconstruction, high-risk tumors, and tumors on specialty sites. Dr. Lewis has authored over 90 peer-reviewed manuscripts in high-impact journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, and Journal of Investigative Dermatology. He has also served on the Editorial Board of the International Journal of Dermatology and has authored multiple textbook chapters as well as two editions of the book Practical Ways to Improve Patient Adherence, named the winner of the 2022 ""Best Overall"" Dermie Award by Dermasphere. Dr. Lewis is an aspiring leader in cutaneous oncology and was named Post-Doctoral Trainee of the Year in 2022 by ADEN, winner of the 2022 ASDS Young Investigators Writing Competition, and a Rising Scholar by the Dermatology Foundation in 2023. He is a member of the Alpha Omega Alpha Honor Medical Society. He is passionate about Mohs micrographic surgery and has clinical interests in advanced facial reconstruction, Mohs surgery with immunohistochemistry, facial anatomy, Merkel cell carcinoma, melanoma, and patient adherence.". Dr. Lewis is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome. Dr. Lewis is board certified in American Board Of Dermatology.

William Burns, M.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine and a surgeon within the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Prior to joining the faculty at Johns Hopkins, Dr. Burns served as an assistant professor of surgery at the University of Michigan, as well as an attending physician at the University of Michigan Health Systems and the VA Ann Arbor Healthcare System. Dr. Burns received his medical degree from Yale University School of Medicine and was awarded a research training fellowship by the Howard Hughes Medical Institute. He completed an internship and residency in general surgery at The Johns Hopkins Hospital followed by clinical fellowship training in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Additionally, he completed postgraduate research fellowships in the field of cancer immunotherapy and tumor immunology at the National Cancer Institute and the MD Anderson Cancer Center. Dr. Burns specializes in treating patients with tumors of the pancreas and gastrointestinal tract, sarcoma and melanoma. He is trained in traditional and minimally invasive surgical techniques. Furthermore, he works closely with colleagues in medical and radiation oncology to provide comprehensive cancer care. His research focuses on immune cell-tumor cell interactions to improve outcomes in patients with pancreatic cancer, cancer immunotherapy for solid tumors, the role of lymph node surgery in the treatment of cancer, and human biospecimen analysis to guide therapy in patients with cancer. He is a member of several professional societies, including the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgery, and Society of Immunotherapy for Cancer. Dr. Burns is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Burns is board certified in American Board Of Surgery.

Blanche Mavromatis, MD, specializes in hematology oncology and is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mavromatis completed her fellowship at Georgetown University Hospital, residency at Georgetown University Medical Center and medical degree from Thomas Jefferson University Medical College. Dr. Mavromatis is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 67 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is board certified in American Board Of Internal Medicine. Dr. Mavromatis is currently accepting new patients.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Adenoidectomy. Dr. Kiess is board certified in American Board Of Radiology.

Dr. Farah Succaria is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. She earned her medical degree from the American University of Beirut, where she also completed her dermatology residency. She next pursued Dermatopathology fellowship at Boston University. After fellowship completion, Dr. Succaria returned to Lebanon and founded a mobile dermatology clinic as part of a non-government organization empowering women to help refugees and displaced children. She then came back to Johns Hopkins and completed a postdoctoral dermatology research fellowship. She is also member of the Taube lab team and is actively involved in research with a main focus on immune checkpoint inhibitors, and the role of the tumor microenvironment in various cancers including melanoma and squamous cell carcinoma. Dr. Succaria is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Actinic Keratosis, Merkel Cell Carcinoma, and Giant Congenital Nevus.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Dr. Creighton is an ear and lateral skull base surgeon. Dr. Creighton graduated from the Georgia Institute of Technology with a Bachelor of Science in biomedical engineering and earned his M.D. from Emory University. He completed a general surgery internship at the Mass General Hospital and residency in otolaryngology-head and neck surgery at Harvard. Following this he completed a fellowship in neurotology and lateral skull base surgery at Johns Hopkins. His clinical practice specializes in surgical and medical management of middle ear, inner ear, skull base and facial nerve disorders. These include skull base tumors, vestibular schwannomas (acoustic neuromas), hearing loss, cholesteatoma, cochlear implantation, stapedectomy, CSF leaks and ear drum perforations. He is trained in minimally invasive and endoscopic approaches to the ear for cholesteatoma and ear drum perforations, which reduces the need for visible incisions, and performed the first in office tympanoplsty repairs at Johns Hopkins. Dr. Creighton is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Schwannoma, Infant Hearing Loss, Mastoidectomy, and Septoplasty. Dr. Creighton is board certified in Head And Neck Surgery.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery. Dr. Kleinberg is board certified in American Board Of Radiology.

Dr. Joel Sunshine is an Assistant Professor of Dermatology, Pathology, Oncology, and Biomedical Engineering at the Johns Hopkins University School of Medicine. He specializes in medical dermatology and skin cancer. His areas of clinical expertise include general dermatology, cutaneous oncology including melanoma and Merkel cell carcinoma, and supportive oncodermatology. Dr. Sunshine obtained his undergraduate degree from Brandeis University, his M.D. and Ph.D. from Johns Hopkins University School of Medicine, and his dermatology residency training and dermatopathology fellowship from the Northwestern University Feinberg School of Medicine. Dr. Sunshine is rated as an Advanced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, and Hidradenitis Suppurativa. Dr. Sunshine is board certified in American Board Of Dermatology.

Linda Wang is a Dermatologist practicing medicine in Lutherville Timonium, Maryland. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Telangiectasia, Spider Angioma, Intertrigo, and Rosacea.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

Adel Mandl is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Mandl is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Prostate Cancer, and Pheochromocytoma.

Kelly Orwat is a Radiologist practicing medicine in Rosedale, Maryland. Dr. Orwat is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Metastatic Brain Tumor, and Primitive Neuroectodermal Tumor (PNET).

Mark Brejt is a Radiologist practicing medicine in Glen Burnie, Maryland. Dr. Brejt is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. His clinical expertise encompasses Melorheostosis with Osteopoikilosis, Osteopenia, Melorheostosis, and Pleurisy.

Zaineb Makhzoumi is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Makhzoumi is rated as an Experienced provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Actinic Keratosis.